Revenue growth was restricted to 7% YoY in Q2FY19 as strong performance in EAP, Americas and Europe region was offset by weak sales in AMESA. EAP revenue grew by 16.6% in Q2FY19 led by increased contribution from non-oral care category while Europe revenue rose by 12% YoY led by strong growth in Poland. AMESA region disappointed with 1.2% YoY decline in revenue in Q2FY19 mainly due to weak...